After the meeting encore on September 26,2020, all registrants will receive an email with directions on how to claim their certificates for MSVirtual2020. To receive CME/CE credit for this meeting, you must attend the learning sessions, complete the online evaluation, and certify the number of credits you are eligible to receive. Upon completion, you will electronically receive your CME/CE certificate. The deadline to claim CME Credit or a Certificate of Participation is Saturday, February 28, 2021.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Interstate Postgraduate Medical Association (IPMA) and ACTRIMS.
The IPMA is accredited by the ACCME to provide continuing medical education for physicians. The IPMA designates this enduring activity for a maximum of 71.65 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Maintenance of Certification (“MOC”) Activities through the ABMS Continuing Certification Directory, MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) and/or for the following ABMS Member Boards:
ABMS Continuing Certification Diplomate Survey
To continue to improve the experience of physicians participating in MOC, please distribute the survey link below to all learners who complete this activity. This survey aims to aggregate feedback from physicians (and related healthcare professionals) on activities indexed in the Continuing Certification Directory and solicits feedback to improve the value of the ABMS Continuing Certification Directory. http://www.surveygizmo.com/s3/3915510/ABMS-Continuing-Certification-Directory-Diplomate-Satisfaction-Survey
If you require clarification of these statements, please contact the CME Office:
Interstate Postgraduate Medical Association (IPMA)
Heidi Ness, Director of Education & Accreditation
Email: [email protected]
Phone: (608) 592‐1622
Learning & Program Objectives
The themes for this conference, designed by the MSVirtual2020 Scientific Program Committee are clinical, pathogenesis, translational, and environmental/genetic factors and were derived from past attendee input and emerging studies and literature.
MSVirtual2020 key areas for education:
Therapeutic strategies for suppressing disease activity and disability accumulation in individuals with radiologically isolated syndrome, relapsing remitting MS and progressive MS
Efficacy of current disease modifying therapies across clinical subsets of individuals with MS
Role of innate immune cells in pathogenic and reparative pathways in MS
Relationship between the gut, microbiome, and disease activity in individuals with MS
Advances in imaging and visual system parameters in the diagnosis, prognosis and monitoring of individuals with MS
Integration of information on environmental, life style, age-related, and genetic/ epigenetic factors in MS risk and clinical course
Use of machine learning approaches in predicting MS risk and clinical course
MSVirtual2020 is supported in part by unrestricted educational grants from the following commercial entities:
As a provider dedicated to independent education and accredited by the ACCME, IPMA must ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All individuals (including their spouse/partner) with potential to influence the content of this program have submitted Conflict of Interest declarations that have been reviewed according to policy and these declarations are listed below. All individuals with potential conflicts have been contacted as needed by IPMA staff, and issues of conflict have been discussed, managed, and mitigated. Disclosures will be shared with MSVirtual2020 attendees prior to the meeting.
Additionally, all faculty have been asked to disclose to learners any discussion of off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States and investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.